Vascular endothelial growth factor (VEGF) fails to predict response to neoadjuvant chemotherapy for primary breast cancer.

類似資料

• Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Inhibitors in Health and Disease
  著者:: Sylvain Broussy
  出版事項: (2024-07-01)
• Predictive Significance of Vascular Endothelial Growth Factor receptor VEGF-2 in triple-negative breast cancer patients
  著者:: N. N. Babyshkina, 等
  出版事項: (2016-11-01)
• Breast Cancer: Neoadjuvant Chemotherapy
  著者:: Barbara F. Shea, 等
  出版事項: (2007-03-01)
• Breast Cancer: Neoadjuvant Chemotherapy
  著者:: Barbara F. Shea, 等
  出版事項: (2015-05-01)
• Breast Cancer: Neoadjuvant Chemotherapy
  著者:: Barbara F. Shea, 等
  出版事項: (2007-03-01)